Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) — Financial Flexibility Index
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) has a Financial Flexibility Index of 0.20x as of September 2025. Free cash flow of CN¥28.21 Million (operating CF CN¥11.57 Million minus capex CN¥16.64 Million) represents 0% of total liabilities (CN¥142.19 Million). Check Hubei Biocause Heilen Pharmaceutical Co. (301211) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Hubei Biocause Heilen Pharmaceutical Co. Ltd. across 9 annual periods. See 301211 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hubei Biocause Heilen Pharmaceutical Co. Ltd. (2017–2025)
Year-by-year free cash flow to debt coverage for Hubei Biocause Heilen Pharmaceutical Co. Ltd.. For the full company profile including market capitalisation, see Hubei Biocause Heilen Pharmaceutical Co. (301211) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | CN¥59.88 Million | CN¥7.55 Million | CN¥128.65 Million | ▼ -68.0% |
| 2024 | 1.46x | CN¥260.50 Million | CN¥96.07 Million | CN¥178.97 Million | ▼ -14.6% |
| 2023 | 1.70x | CN¥323.60 Million | CN¥137.06 Million | CN¥189.89 Million | ▲ +15.4% |
| 2022 | 1.48x | CN¥326.75 Million | CN¥250.79 Million | CN¥221.22 Million | ▲ +9.5% |
| 2021 | 1.35x | CN¥145.05 Million | CN¥123.98 Million | CN¥107.53 Million | ▲ +2.7% |
| 2020 | 1.31x | CN¥135.06 Million | CN¥121.67 Million | CN¥102.85 Million | ▼ -16.5% |
| 2019 | 1.57x | CN¥404.67 Million | CN¥372.33 Million | CN¥257.31 Million | ▲ +273.3% |
| 2018 | 0.42x | CN¥101.26 Million | CN¥76.18 Million | CN¥240.36 Million | ▲ +283.0% |
| 2017 | -0.23x | CN¥-52.32 Million | CN¥-65.44 Million | CN¥227.25 Million | — |